{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:30:53Z","timestamp":1778945453856,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Isaacs\u2019 syndrome is a peripheral nerve hyperexcitability (PNH) syndrome due to peripheral motor nerve instability. Acquired Isaacs\u2019 syndrome is recognized as a paraneoplastic autoimmune disease with possible pathogenic voltage-gated potassium channel (VGKC) complex antibodies. However, the longitudinal correlation between clinical symptoms, VGKC antibodies level, and drug response is still unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 45-year-old man had progressive four limbs soreness, muscle twitching, cramps, and pain 4\u2009months before admission. Electromyography (EMG) studies showed myokymic discharges, neuromyotonia, and an incremental response in the high-rate (50\u2009Hz) repetitive nerve stimulation (RNS) test. Isaacs\u2019 syndrome was diagnosed based on clinical presentations and EMG reports. Serum studies showed positive VGKC complex antibodies, including leucine-rich glioma-inactivated 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) antibodies. The acetylcholine receptor antibody was negative. Whole-body computed tomography (CT) and positron emission tomography revealed a mediastinal tumor with the great vessels encasement, right pleura, and diaphragm seeding. Biopsy confirmed a World Health Organization type B2 thymoma, with Masaoka stage IVa. His symptoms gradually improved and both LGI1 and CASPR2 antibodies titer became undetectable after concurrent chemoradiotherapy (CCRT) and high dose steroid treatment. However, his Isaacs\u2019 syndrome recurred after the steroid was reduced 5\u2009months later. Follow-up chest CT showed probable thymoma progression. LGI1 antibody turned positive again while CASPR2 antibody remained undetectable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our patient demonstrates that Isaacs\u2019 syndrome could be the initial and only neuromuscular manifestation of malignant thymoma. His Isaacs\u2019 syndrome is correlated well with the LGI1 antibody level. With an unresectable thymoma, long-term immunosuppressant therapy may be necessary for the management of Isaacs\u2019 syndrome in addition to CCRT for thymoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02584-7","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:38:28Z","timestamp":1646401108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Isaacs\u2019 syndrome as the initial presentation of malignant thymoma and associated with double-positive voltage-gated potassium channel complex antibodies, a case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Kuan-Ching","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Feng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Kuo","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"issue":"5","key":"2584_CR1","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1212\/CON.0000000000000520","volume":"23","author":"K Sawlani","year":"2017","unstructured":"Sawlani K, Katirji B. Peripheral nerve Hyperexcitability syndromes. Continuum (Minneap Minn). 2017;23(5) Peripheral Nerve and Motor Neuron Disorders:1437\u201350. https:\/\/doi.org\/10.1212\/CON.0000000000000520.","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"2584_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/NRL.0b013e3181870aa2","volume":"15","author":"TB Toothaker","year":"2009","unstructured":"Toothaker TB, Rubin M. Paraneoplastic neurological syndromes: a review. Neurologist. 2009;15(1):21\u201333. https:\/\/doi.org\/10.1097\/NRL.0b013e3181870aa2.","journal-title":"Neurologist."},{"issue":"12","key":"2584_CR3","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jamaneurol.2018.2681","volume":"75","author":"A Vincent","year":"2018","unstructured":"Vincent A, Pettingill P, Pettingill R, Lang B, Birch R, Waters P, et al. Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-associated protein 2, and Contactin 2 antibodies with clinical features and patient-reported pain in acquired Neuromyotonia. JAMA Neurol. 2018;75(12):1519\u201327. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2681.","journal-title":"JAMA Neurol"},{"issue":"5","key":"2584_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","volume":"89","author":"SNM Binks","year":"2018","unstructured":"Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry. 2018;89(5):526\u201334. https:\/\/doi.org\/10.1136\/jnnp-2017-315720.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2584_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mus.24632","volume":"52","author":"A Ahmed","year":"2015","unstructured":"Ahmed A, Simmons Z. Isaacs syndrome: a review. Muscle Nerve. 2015;52(1):5\u201312. https:\/\/doi.org\/10.1002\/mus.24632.","journal-title":"Muscle Nerve"},{"key":"2584_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fneur.2019.00516","volume":"10","author":"K Huang","year":"2019","unstructured":"Huang K, Luo YB, Yang H. Autoimmune Channelopathies at neuromuscular junction. Front Neurol. 2019;10:516. https:\/\/doi.org\/10.3389\/fneur.2019.00516.","journal-title":"Front Neurol"},{"issue":"1","key":"2584_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","volume":"15","author":"C Bernard","year":"2016","unstructured":"Bernard C, Frih H, Pasquet F, Kerever S, Jamilloux Y, Tronc F, et al. Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev. 2016;15(1):82\u201392. https:\/\/doi.org\/10.1016\/j.autrev.2015.09.005.","journal-title":"Autoimmun Rev"},{"issue":"7","key":"2584_CR8","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/ene.13922","volume":"26","author":"M Gastaldi","year":"2019","unstructured":"Gastaldi M, De Rosa A, Maestri M, Zardini E, Scaranzin S, Guida M, et al. Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study. Eur J Neurol. 2019;26(7):992\u20139. https:\/\/doi.org\/10.1111\/ene.13922.","journal-title":"Eur J Neurol"},{"issue":"11","key":"2584_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.nmd.2006.07.002","volume":"16","author":"K Fukushima","year":"2006","unstructured":"Fukushima K, Sato T, Mitsuhashi S, Kaneko K, Yazaki M, Matsuda M, et al. Isaacs' syndrome associated with myasthenia gravis, showing remission after cytoreductive surgery of pleural recurrence of thymoma. Neuromuscul Disord. 2006;16(11):763\u20135. https:\/\/doi.org\/10.1016\/j.nmd.2006.07.002.","journal-title":"Neuromuscul Disord"},{"issue":"1\u20132","key":"2584_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/s0022-510x(00)00407-x","volume":"181","author":"GR Hayat","year":"2000","unstructured":"Hayat GR, Kulkantrakorn K, Campbell WW, Giuliani MJ. Neuromyotonia: autoimmune pathogenesis and response to immune modulating therapy. J Neurol Sci. 2000;181(1\u20132):38\u201343. https:\/\/doi.org\/10.1016\/s0022-510x(00)00407-x.","journal-title":"J Neurol Sci"},{"key":"2584_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jocn.2017.02.063","volume":"41","author":"J Song","year":"2017","unstructured":"Song J, Jing S, Quan C, Lu J, Qiao X, Qiao K, et al. Isaacs syndrome with CASPR2 antibody: a series of three cases. J Clin Neurosci. 2017;41:63\u20136. https:\/\/doi.org\/10.1016\/j.jocn.2017.02.063.","journal-title":"J Clin Neurosci"},{"issue":"5","key":"2584_CR12","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1212\/wnl.50.5.1483","volume":"50","author":"F Heidenreich","year":"1998","unstructured":"Heidenreich F, Vincent A. Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy. Neurology. 1998;50(5):1483\u20135. https:\/\/doi.org\/10.1212\/wnl.50.5.1483.","journal-title":"Neurology."},{"issue":"4","key":"2584_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/CND.0b013e318246197d","volume":"13","author":"SS Rana","year":"2012","unstructured":"Rana SS, Ramanathan RS, Small G, Adamovich B. Paraneoplastic Isaacs' syndrome: a case series and review of the literature. J Clin Neuromuscul Dis. 2012;13(4):228\u201333. https:\/\/doi.org\/10.1097\/CND.0b013e318246197d.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"10","key":"2584_CR14","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/jamaneurol.2013.2863","volume":"70","author":"J Fleisher","year":"2013","unstructured":"Fleisher J, Richie M, Price R, Scherer S, Dalmau J, Lancaster E. Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis. JAMA Neurol. 2013;70(10):1311\u20134. https:\/\/doi.org\/10.1001\/jamaneurol.2013.2863.","journal-title":"JAMA Neurol"},{"issue":"7","key":"2584_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4103\/0019-5359.99866","volume":"64","author":"BS Paul","year":"2010","unstructured":"Paul BS, Singh G, Bansal RK, Singla M. Isaac's syndrome associated with myasthenia gravis and thymoma. Indian J Med Sci. 2010;64(7):320\u20134. https:\/\/doi.org\/10.4103\/0019-5359.99866.","journal-title":"Indian J Med Sci"},{"issue":"9","key":"2584_CR16","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1111\/j.1468-1331.2012.03805.x","volume":"19","author":"L Ozcakar","year":"2012","unstructured":"Ozcakar L, Ozcan HN, Dizdar O, Karaoglanoglu N, Tan E. Neuromyotonia forerunning the diagnosis of an eventual thymoma. Eur J Neurol. 2012;19(9):e98\u20139. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03805.x.","journal-title":"Eur J Neurol"},{"issue":"10 Pt B","key":"2584_CR17","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/j.bbamem.2015.04.003","volume":"1848","author":"B Joubert","year":"2015","unstructured":"Joubert B, Honnorat J. Autoimmune channelopathies in paraneoplastic neurological syndromes. Biochim Biophys Acta. 2015;1848(10 Pt B):2665\u201376. https:\/\/doi.org\/10.1016\/j.bbamem.2015.04.003.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"2584_CR18","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010;133(9):2734\u201348. https:\/\/doi.org\/10.1093\/brain\/awq213.","journal-title":"Brain"},{"issue":"2","key":"2584_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","volume":"70","author":"CJ Klein","year":"2013","unstructured":"Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A, et al. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol. 2013;70(2):229\u201334. https:\/\/doi.org\/10.1001\/jamaneurol.2013.592.","journal-title":"JAMA Neurol"},{"issue":"12","key":"2584_CR20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/jnnp-2020-324675","volume":"91","author":"SB Park","year":"2020","unstructured":"Park SB, Thurbon R, Kiernan MC. Isaacs syndrome: the frontier of neurology, psychiatry, immunology and cancer. J Neurol Neurosurg Psychiatry. 2020;91(12):1243\u20134. https:\/\/doi.org\/10.1136\/jnnp-2020-324675.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"2584_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.nrl.2013.12.007","volume":"30","author":"MT Montojo","year":"2015","unstructured":"Montojo MT, Petit-Pedrol M, Graus F, Dalmau J. Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex. Neurologia. 2015;30(5):295\u2013301. https:\/\/doi.org\/10.1016\/j.nrl.2013.12.007.","journal-title":"Neurologia."},{"issue":"9 Suppl 2","key":"2584_CR22","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1097\/JTO.0000000000000300","volume":"9","author":"A Evoli","year":"2014","unstructured":"Evoli A, Lancaster E. Paraneoplastic disorders in thymoma patients. J Thorac Oncol. 2014;9(9 Suppl 2):S143\u20137. https:\/\/doi.org\/10.1097\/JTO.0000000000000300.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"2584_CR23","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1212\/wnl.30.6.634","volume":"30","author":"M Lauritzen","year":"1980","unstructured":"Lauritzen M, Smith T, Fischer-Hansen B, Sparup J, Olesen J. Eaton-Lambert syndrome and malignant thymoma. Neurology. 1980;30(6):634\u20138. https:\/\/doi.org\/10.1212\/wnl.30.6.634.","journal-title":"Neurology."},{"issue":"6","key":"2584_CR24","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.athoracsur.2009.11.041","volume":"89","author":"M Morimoto","year":"2010","unstructured":"Morimoto M, Osaki T, Nagara Y, Kodate M, Motomura M, Murai H. Thymoma with Lambert-Eaton myasthenic syndrome. Ann Thorac Surg. 2010;89(6):2001\u20133. https:\/\/doi.org\/10.1016\/j.athoracsur.2009.11.041.","journal-title":"Ann Thorac Surg"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02584-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02584-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02584-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:41:27Z","timestamp":1646401287000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02584-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2584"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02584-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"26 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Chang Gung Memorial Hospital and University (License no: 202100774B0).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained written consent for the publication from the patient for their personal or clinical details and any accompanying images. This report does not contain any personal information that could lead to the identification of the patient. The copy of the consent form is available for review by the Editor of BMC neurology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}